Details for New Drug Application (NDA): 016750
✉ Email this page to a colleague
NDA 016750 describes CORTROSYN, which is a drug marketed by Amphastar Pharms Inc and is included in one NDA. It is available from three suppliers. Additional details are available on the CORTROSYN profile page.
The generic ingredient in CORTROSYN is cosyntropin. There are two drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the cosyntropin profile page.
The generic ingredient in CORTROSYN is cosyntropin. There are two drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the cosyntropin profile page.
Summary for 016750
| Tradename: | CORTROSYN |
| Applicant: | Amphastar Pharms Inc |
| Ingredient: | cosyntropin |
| Patents: | 0 |
Suppliers and Packaging for NDA: 016750
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| CORTROSYN | cosyntropin | INJECTABLE;INJECTION | 016750 | NDA | Henry Schein, Inc. | 0404-9839 | 0404-9839-99 | 1 VIAL in 1 BAG (0404-9839-99) / 1 mL in 1 VIAL |
| CORTROSYN | cosyntropin | INJECTABLE;INJECTION | 016750 | NDA | Amphastar Pharmaceuticals, Inc. | 0548-5900 | 0548-5900-00 | 10 VIAL in 1 CARTON (0548-5900-00) / 1 mL in 1 VIAL |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INJECTION | Strength | 0.25MG/VIAL | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | AP | RLD: | Yes | ||||
Complete Access Available with Subscription
